AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, Californ
February 19 2008 - 7:30AM
PR Newswire (US)
QUEBEC CITY, Feb. 19 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (NASDAQ:AEZSNASDAQ:TSX:NASDAQ:AEZ), a global biopharmaceutical
company focused on endocrine therapy and oncology, today announced
that its President and CEO, David J. Mazzo, Ph.D., will present a
company overview at the Roth Capital Partners 20th Annual OC Growth
Stock Conference on February 20, 2008 at 4:00 pm PT, in the
Ballroom of the Ritz Carlton Laguna Niguel in Dana Point,
California. A live webcast of this presentation will be available
on AEterna Zentaris' website at http://www.aezsinc.com/ in the
Investors section. A replay will also be available for a period of
30 days on the Company's website. About AEterna Zentaris Inc.
AEterna Zentaris Inc. is global biopharmaceutical company focused
on endocrine therapy and oncology with proven expertise in drug
discovery, development and commercialization. News releases and
additional information are available at http://www.aezsinc.com/.
DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Jenene Thomas, Senior
Director, Investor Relations & Corporate Communications, (908)
626-5509, ; Paul Burroughs, Media Relations, (418) 652-8525, ext.
406,
Copyright
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jul 2023 to Jul 2024